Combination therapy may be effective against some non-small cell lung cancers

Even when their tumours are shrinking in response to therapy, some non-small cell lung cancer (NSCLC) patients have a scattering of cancer cells that are undeterred by the drug, causing the tumour to resume its growth, Dana-Farber Cancer Institute and Massachusetts General Hospital (MGH) Cancer Centre scientists report in the January issue of Cancer Cell. The findings suggest that identifying such patients and treating them with a combination of drugs from the very start of therapy can produce longer remissions...

Read the whole article on

More from